citation_index
TL2 Member · Cologne, DE
Keeps a personal log and shares the numbers when they are relevant, with the measurement caveats attached.
Joined 19 September 2025 · last posted 15h
91 posts, newest first. Showing up to 150.
-
Restarting after a long gap: what the labelling implies Replied, post #47 · Practice › Dosing & titration · 27 Jul 2026 · 0 likes This follows post #44 rather than contradicting it. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the…
-
Here for the analytics and not much else Replied, post #93 · Lounge › Introductions · 26 Jul 2026 · 0 likes If you are arriving from somewhere louder, the pace here will feel slow. A topic can sit for two days and then get a reply that is worth the wait. That is the design…
-
What a certificate commits its issuer to Replied, post #103 · Analytics › COA interpretation · 25 Jul 2026 · 2 likes Post #102 is the version of this I will quote in future. One addition. The distinction between release testing and characterisation is one industrial documents make and…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #70 · Clinical › Prescriber conversations · 24 Jul 2026 · 19 likes Adding a data point of agreement rather than a data point.
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #60 · Sourcing › Regulatory · 23 Jul 2026 · 8 likes Everything in post #56 holds. The case it does not cover is the one I have. Where I have landed on compounding permissions, having got it wrong once in public: the…
-
Follow-up: Signs of dehydration worth acting on Replied, post #35 · Safety › Adverse events · 23 Jul 2026 · 20 likes Careful with the language on Signs of dehydration worth acting. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
What is genuinely unknown about long-term amylin agonism Replied, post #69 · Compounds › Cagrilintide & amylin analogues · 22 Jul 2026 · 22 likes Research-use-only cagrilintide is not approved for human use and the published evidence base is a clinical-trial evidence base. Those two facts sit uncomfortably…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #78 · Analytics › Home & field testing · 16 Jul 2026 · 0 likes Picking up post #77: that is the part I would want checked first. A home refractometer is not measuring what people hope it is measuring in these preparations, and the…
-
Travelling with an injectable: documentation and practicalities Replied, post #40 · Access › International · 14 Jul 2026 · 22 likes Regional practice around what a pharmacy will and will not do varies enormously and is not deducible from the regulatory position.
-
Tracking intake honestly when appetite is absent Replied, post #96 · Nutrition & Training › Protein & intake · 13 Jul 2026 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #3 · Compounds › Tirzepatide · 12 Jul 2026 · 0 likes On the mechanism question specifically: the honest position is that GIP agonism plausibly contributes and that the trial design cannot separate its contribution from…
-
What a certificate commits its issuer to Replied, post #6 · Analytics › COA interpretation · 9 Jul 2026 · 22 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #84 · Analytics › Home & field testing · 7 Jul 2026 · 16 likes A test that gives a yes or no on the presence of peptide bonds is answering a genuinely useful question if that is the question you had. It is not a purity assay and…
-
Coming back to: Batch date after test date, and other internal inconsistencies Started this topic · Analytics › COA interpretation · 30 Jun 2026 · 5 likes On the subject in the title: Batch date after test date, and other internal inconsistencies Working notes rather than a conclusion. Batch date — I have the observation…
-
Second pass at: Programming during a large energy deficit Replied, post #16 · Nutrition & Training › Resistance training · 6 Jun 2026 · 21 likes Where training is new, the early gains are largely neural, which is why they can appear even during a deficit and do not indicate tissue change. I keep a log of this…
-
About the COA interpretation category Replied, post #13 · Analytics › COA interpretation · 31 May 2026 · 2 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Batch numbers that do not match the vial label Replied, post #23 · Sourcing › Red flags · 31 May 2026 · 0 likes Answering the question post #19 raises rather than the one it answers. A certificate whose lot number does not match the vial is a stop-and-ask, not a conclusion. Most…
-
Injection volume, overload, and peak distortion Replied, post #23 · Analytics › HPLC & UHPLC · 27 May 2026 · 31 likes Confirming post #22 from a second method, which matters more than confirming it from a second person. A chromatogram image at a resolution where you can see peak shape…
-
Request: a per-category review queue Replied, post #6 · Meta › Feature requests · 27 May 2026 · 28 likes Request from the analytics side: allow a table in a post to be marked as data rather than layout, so it can be copied without the formatting. Half the tables here are…
-
Reading a home test result without over-claiming Replied, post #45 · Analytics › Home & field testing · 17 May 2026 · 12 likes Answering the question post #41 raises rather than the one it answers. Why third-party testing is stronger: a home test run by the person who made the compound is a…
-
Spreadsheets: an appreciation — what changed since Replied, post #26 · Lounge › Off topic · 24 Apr 2026 · 9 likes Practical answer on Spreadsheets, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
-
Journal club: is percentage weight change the right endpoint? Replied, post #55 · Evidence › Journal club · 10 Apr 2026 · 5 likes That is a cleaner way of putting what I was circling around.
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #8 · Devices › Syringes & needles · 4 Apr 2026 · 2 likes Confirming post #7 from a second method, which matters more than confirming it from a second person. Sharps containers are a legal requirement for disposal in several…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #27 · Practice › Administration · 3 Apr 2026 · 0 likes Nothing in this subcategory is medical advice and none of it is a substitute for a demonstration from somebody qualified to give one, which most prescribers will do…
-
[2026 update] What a purity-only report leaves out Replied, post #72 · Sourcing › Independent verification · 30 Mar 2026 · 1 like This settles it for me, at least until somebody posts a reason it should not.
-
Run-in periods and the population they select Replied, post #83 · Evidence › Trials · 17 Mar 2026 · 4 likes The arithmetic in post #82 is right; the assumption feeding it is the part to check. Absolute and relative effects answer different questions. Write down the event rate…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #102 · Pharmacology › Pharmacokinetics · 10 Mar 2026 · 25 likes Subcutaneous absorption is the rate-limiting step for most of these compounds, which is why the apparent half-life is absorption-limited rather than elimination-limited.
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #75 · Practice › Storage & stability · 3 Mar 2026 · 0 likes Post #74 is right about the mechanism and I think understates the practical bit. An update on my earlier Storing lyophilised material long term post: the pattern held…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #59 · Regional › UK & Ireland · 1 Mar 2026 · 13 likes Summarising the pharmacy supply thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the…
-
Measurement error in a self-reported exposure Replied, post #81 · Evidence › Study critique · 26 Feb 2026 · 8 likes Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #61 · Evidence › Study critique · 17 Feb 2026 · 4 likes Surrogate endpoints are not automatically bad and their validity is compound-specific and population-specific. The question is whether this surrogate has been validated…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #43 · Analytics › Impurities & related substances · 17 Feb 2026 · 12 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
Trifluoroacetate content and its consequences Replied, post #80 · Analytics › Impurities & related substances · 4 Feb 2026 · 22 likes Answering the question post #77 raises rather than the one it answers. Relative response factors mean impurities are not detected in proportion to how much of them is…
-
What a certificate commits its issuer to — one year on Replied, post #8 · Analytics › COA interpretation · 23 Jan 2026 · 22 likes I read post #7 twice before replying, because I had assumed the opposite. Asking for the batch record rather than the certificate is a reasonable request and the…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #38 · Practice › Interactions · 20 Jan 2026 · 10 likes On Common supplements: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply…
-
Specification in the result column: why that is a meaningful error Replied, post #102 · Analytics › COA interpretation · 9 Jan 2026 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Preprint servers and what screening they do Replied, post #17 · Evidence › Preprints · 6 Jan 2026 · 0 likes Say it is a preprint in the first line rather than the last. Everything downstream depends on that status and readers arriving from search will not scroll for it.
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #67 · Practice › Side effects · 28 Dec 2025 · 24 likes Post #66 is the version of this I will quote in future. One addition. The relationship between symptom burden and outcome is not what people assume. Feeling worse is…
-
Journal club: LEADER as the historical anchor Replied, post #14 · Evidence › Journal club · 20 Dec 2025 · 23 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. I keep a log of this specifically because memory is…
-
Tirzepatide's shorter half-life and its one practical consequence Replied, post #28 · Compounds › Tirzepatide · 10 Dec 2025 · 9 likes Everything in post #26 holds. The case it does not cover is the one I have. On purity: the trailing-edge features people report on tirzepatide chromatograms are…
-
Documentation that materially improves an appeal's chances Replied, post #93 · Access › Insurance & coverage · 7 Dec 2025 · 0 likes Appeal deadlines are strict and are stated in the letter. Missing one is the most avoidable way to lose. I would call that likely rather than established.
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #22 · Practice › Reconstitution · 23 Nov 2025 · 1 like Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #97 · Safety › Adverse events · 5 Nov 2025 · 20 likes Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with personal or family history of MTC or multiple endocrine neoplasia type 2.…
-
How to read a forest plot, properly, from scratch Replied, post #49 · Evidence › Trials · 2 Nov 2025 · 1 like Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #74 · Safety › Adverse events · 30 Oct 2025 · 6 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Sleep tracking data and its considerable limitations Replied, post #83 · Wellbeing › Sleep · 25 Oct 2025 · 0 likes Everything in post #82 holds. The case it does not cover is the one I have. Caffeine and alcohol both affect sleep architecture and both change during a period of…
-
A 40-week log with the measurement method stated Replied, post #61 · Outcomes › Progress reports · 24 Oct 2025 · 9 likes Noted, and I have changed what I was going to do on the strength of it.
-
Reading an interaction checker output critically Replied, post #27 · Practice › Interactions · 22 Oct 2025 · 0 likes Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is no published interaction study, and the…
-
New subcategory: rationale and scope Replied, post #80 · Meta › Announcements · 21 Oct 2025 · 0 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
-
Second pass at: The mass-error checker and its intended scope Replied, post #35 · Data & Tools › Calculators · 10 Oct 2025 · 2 likes Adding a data point of agreement rather than a data point.
-
Research-use-only labelling: what it means and what it does not Replied, post #41 · Sourcing › Regulatory · 3 Oct 2025 · 2 likes Reporting rather than recommending, on research-use-only labelling. What happened is above. Whether it should have is a different question and not one I am qualified to…
-
Particulates in a reconstituted solution: identifying the likely source Replied, post #10 · Analytics › Impurities & related substances · 28 Sep 2025 · 0 likes On particulates, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
-
Trust level 3 requirements: a clarification Replied, post #9 · Meta › Announcements · 23 Sep 2025 · 0 likes On trust level 3 requirements: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #61 · Practice › Administration · 14 Sep 2025 · 18 likes I had written a reply contradicting post #57 and deleted it. Here is what survived. I think the pinch question is answerable and has not been answered, which is a more…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #38 · Sourcing › Vendor reports · 11 Aug 2025 · 17 likes That is the distinction I keep failing to hold on to. Written down now.
-
Angle of injection and whether 90 degrees is always right Replied, post #9 · Practice › Administration · 10 Aug 2025 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. That is…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #43 · Evidence › Journal club · 21 Jul 2025 · 30 likes An hour is enough for one paper read properly and not enough for two read partly. The temptation is always to add the second. Written quickly, so the reasoning may be…
-
Random versus fixed effects: choosing rather than defaulting Replied, post #11 · Evidence › Meta-analyses · 25 Jun 2025 · 12 likes That is the distinction I keep failing to hold on to. Written down now.
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #158 · Compounds › Cagrilintide & amylin analogues · 20 Jun 2025 · 10 likes Confirming post #157 from a second method, which matters more than confirming it from a second person. Worth separating CagriSema phase 2 paper as a question about the…
-
Sodium, potassium and magnesium when intake drops Started this topic · Nutrition & Training › Hydration & electrolytes · 29 May 2025 · 2 likes On the subject in the title: Sodium, potassium and magnesium when intake drops Working notes rather than a conclusion. A hydration and intake question, with the…
-
Certificates issued by the seller versus by a laboratory Replied, post #53 · Analytics › COA interpretation · 20 Apr 2025 · 7 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Follow-up: The topic list is dense — is that deliberate? Replied, post #3 · Meta › Site feedback · 11 Apr 2025 · 0 likes On the opening post — agreed on the reasoning, with one qualification. The counter-argument is that a review date on a topic implies a maintenance promise nobody has…
-
What a 2 ppm match establishes, and what it does not Replied, post #10 · Analytics › Mass spectrometry · 8 Apr 2025 · 15 likes Where I part company with post #7, and it is a narrow parting. The honest summary of what a mass result buys you: it narrows the field of what the material could be,…
-
A report I filed that turned out to be wrong, and the correction Replied, post #2 · Sourcing › Vendor reports · 1 Apr 2025 · 25 likes Marking my place. If it changes for me I will come back and say so.
-
An orphaned page with no inbound links Replied, post #23 · Meta › Wiki maintenance · 31 Mar 2025 · 27 likes Post #19 describes the usual case. This is about the unusual one. On orphaned page the community has more anecdote than the confidence in this thread implies, and I…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #6 · Sourcing › Independent verification · 20 Mar 2025 · 8 likes Post #3 answers the question as asked. The question underneath it is different. The record shows what was measured. Everything beyond that is inference and this site…
-
Reading order for a first week here, and what to skip until later Replied, post #27 · Start Here › Welcome · 7 Mar 2025 · 0 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #117 · Compounds › Semaglutide · 28 Feb 2025 · 0 likes Confirming post #116 from a second method, which matters more than confirming it from a second person. Since Semaglutide half-life keeps coming up, it should probably…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #26 · Compounds › Tirzepatide · 22 Feb 2025 · 6 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #7 · Practice › Reconstitution · 2 Feb 2025 · 0 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #36 · Compounds › Semaglutide · 23 Jan 2025 · 28 likes That is a cleaner way of putting what I was circling around.
-
Second pass at: Historical amylin analogues and what happened to them Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 1 Jan 2025 · 0 likes What would change my mind on Historical amylin analogues is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #31 · Compounds › Oral incretins · 26 Dec 2024 · 25 likes Narrowing post #30, because the general version has more than one answer. On variability: the between-person spread in exposure for oral semaglutide is wide enough that…
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #42 · Evidence › Trials · 18 Dec 2024 · 5 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #70 · Practice › Side effects · 13 Dec 2024 · 1 like Picking up post #69: that is the part I would want checked first. What I would tell a new member reading about injection-site reactions for the first time: the…
-
Washout with a one-week half-life: the arithmetic Replied, post #30 · Research Methods › N-of-1 designs · 28 Nov 2024 · 0 likes I disagree with the framing of washout above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked. The…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #26 · Evidence › Journal club · 7 Nov 2024 · 1 like Adding a data point of agreement rather than a data point.
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #61 · Devices › Syringes & needles · 6 Nov 2024 · 0 likes Worth separating two things that post #59 runs together. I would rather this thread reach "we do not know" about Dead volume across syringe than reach a confident…
-
US compounding rules and how they changed Replied, post #57 · Regional › North America · 5 Nov 2024 · 0 likes Cross-border purchasing raises both a legal question and a practical one, and the legal one is yours to establish for your own jurisdiction. Caveat: everything above…
-
Individual participant data versus aggregate data Replied, post #6 · Evidence › Meta-analyses · 30 Oct 2024 · 22 likes Individual participant data pooling is a much stronger design than aggregate pooling and is rare because it requires cooperation rather than a search. The rule of thumb…
-
Requesting a page: what makes a good request — what changed since Replied, post #6 · Documentation › Wiki requests · 9 Oct 2024 · 0 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #11 · Wellbeing › Mental health · 1 Oct 2024 · 27 likes Confirming post #8 from a second method, which matters more than confirming it from a second person. Where the Food noise reasoning breaks down for me is the step from…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #19 · Compounds › Other compounds · 26 Sep 2024 · 14 likes Noted, and thank you for writing it out rather than summarising it.
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #57 · Analytics › COA interpretation · 17 Sep 2024 · 7 likes Helpful, and short, which on this subject is harder than long.
-
When to suspect the method rather than the sample Replied, post #9 · Analytics › Method validation · 5 Sep 2024 · 0 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #89 · Compounds › Retatrutide · 22 Jul 2024 · 17 likes An update on my earlier Retatrutide dose escalation post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #23 · Clinical › Prescriber conversations · 19 Jul 2024 · 0 likes Take the actual numbers and the actual dates. A printed table beats a description and takes the first five minutes out of the appointment. Somebody will have a better…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #10 · Devices › Syringes & needles · 16 Jul 2024 · 0 likes The reason Dead volume across syringe is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the…
-
Journal club: FLOW and the renal composite, component by component Replied, post #71 · Evidence › Journal club · 16 Jul 2024 · 24 likes I read post #70 twice before replying, because I had assumed the opposite. Where the group cannot agree, record the disagreement rather than resolving it by seniority.…
-
How this community labels and discusses unrefereed work Replied, post #31 · Evidence › Preprints · 21 Jun 2024 · 9 likes Post #27 put the caveat in the right place and I want to underline it. Reading a preprint properly means doing some of the reviewer's job: methods first, then whether…
-
Assessing a warm arrival: the decision process — one year on Replied, post #34 · Sourcing › Logistics · 29 May 2024 · 19 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance. Filing this under things that are true until someone…